CONGRESSIONAL KEYNOTE SPEAKER
Congressman Timothy Murphy, Ph.D.
Representing the 18th District of Pennsylvania
Helping Families in Mental Health Crisis Act
In January 2013, Congressman Tim Murphy, Ph.D. of Upper St. Clair began serving his sixth term in Congress representing the 18th District of Pennsylvania, encompassing the South Hills of Pittsburgh and portions of Greene, Allegheny, Washington and Westmoreland counties.
Congressman Murphy relies on his three decades as a psychologist to advocate for meaningful reforms in the U.S. healthcare system. Back home in Southwestern Pennsylvania, Dr. Murphy specialized in child and family treatment and served at a number of hospitals in the Pittsburgh area, including Pittsburgh Children’s Hospital, Mercy Hospital, Magee Women’s Hospital, Transitional Infant Care and St. Margaret’s Hospital.
He holds two adjunct faculty positions with the University of Pittsburgh, serving as an Associate Professor in the Department of Public Health and in the Department of Pediatrics. While working in the hospitals and in his own private practice, he became widely known as “Dr. Tim” through regular appearances on local and national radio and television. Congressman Murphy is also the author of two books: the award-winning book The Angry Child (2001), and Overcoming Passive-Aggression (2005).
As one of only a handful of members of Congress with a background in healthcare and the only child psychologist, Tim quickly established himself as a leader on the issue. He is Co-chair of the Mental Health Caucus and a founding member of the GOP Doctors Caucus, giving him a platform to educate other members of Congress and the public on ways to make healthcare more affordable and accessible for all families.
Last December, following a year-long investigation as Chairman of the Energy & Commerce Subcommittee on Oversight & Investigations into the nation’s broken mental health system, Murphy unveiled landmark mental health reform legislation, the Helping Families In Mental Health Crisis Act (H.R. 3717). Praise and support for the Helping Families In Mental Health Crisis Act has poured in across the country from the American Psychiatric Association, National Alliance on Mental Illness, and numerous media outlets such as CNN, the Wall Street Journal, and Pittsburgh Post-Gazette. Two major components of the Murphy bill were adopted by both the House and Senate and signed into law late March.
On Wednesday April 2nd, the Wall Street Journal editorial board for the second time weighed in on H.R. 3717, praising the bill for “reorganiz[ing] government to make it more effective and accountable” and delivering evidence-based medical care to those most in need of it: persons with serious mental illness like schizophrenia and bipolar disorder. The WSJ editors criticized existing federal efforts, writing that “SAMHSA is in the vanguard of the legal-advocacy and anti-psychiatry movement that sprang to life in the 1980s, and it continues to waste taxpayer dollars on programs that undercut efforts to help the world's Adam Lanzas.” Read the full editorial here. Murphy’s bill makes significant reforms to federal policies and SAMHSA programs to ensure resources are reallocated to those most in need of care can receive it in inpatient and outpatient settings.
In addition to his work in Congress, Rep. Murphy serves as a Lieutenant Commander in the U.S. Navy Reserve Medical Service Corps, working with wounded warriors with Traumatic Brain Injury and Post Traumatic Stress Disorder.
Dr. Murphy earned a bachelor’s degree from Wheeling Jesuit University, a master’s degree from Cleveland State University, and his PhD from the University of Pittsburgh.
Former NFL Player & Superbowl Champion
President & Founder, 4th and Forever Foundation
Keith O’Neil is a former NFL football player having played for the Dallas Cowboys, Indianapolis Colts and New York Giants. During his professional career, he served as team captain and was a member of the Colts Super Bowl XLI Championship team. Keith is currently the President and Founder of the 4th and Forever Foundation which brings awareness to mental health and funds research for mental illness. Keith played in the NFL with the undiagnosed mental illness, bipolar disorder, and is extremely passionate about helping others who suffer. He is devoted to eliminating the stigma of mental illness in society by sharing his own personal experience. He believes, “with the proper diagnosis, medical attention and determination, anyone can achieve anything. If I can make it in the high stress environment of playing in the NFL with bipolar disorder, anything is possible!”
Jeffrey Borenstein, M.D.
President & CEO
Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., a board-certified psychiatrist with more than two decades experience in health care and non-profit leadership, was appointed president and CEO of the Brain & Behavior Research Foundation in 2012. He spent 16 years as CEO and Medical Director of Holliswood Hospital. Since 2006, he has hosted “Healthy Minds,” the Emmy award-nominated public television series he developed to educate the public, reduce stigma, and offer hope to those suffering with mental illness and their families. Produced by WLIW in association with WNET, the program is distributed nationally. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association; and Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons. Dr. Borenstein has a degree from Harvard University and a medical degree from New York University School of Medicine.
William T. Carpenter, Jr., M.D.
Professor of Psychiatry and Pharmacology
University of Maryland School of Medicine
Dr. Carpenter’s major research interest is severe mental illness, particularly schizophrenia. His approach to the care and study of patients encompasses a medical model integrating biological, psychological and social data pertinent to diagnosis, treatment and etiology. His work has led to fundamental contributions in psychopathology, assessment methodology, testing of new treatments and research ethics. His current research is on integrating animal, human and clinical models to develop novel therapeutics.
Dr. Carpenter began his research at the National Institute of Mental Health and he then collaborated in the World Health Organization's International Pilot Study of Schizophrenia. Dr. Carpenter has given expert testimony in the cases of U.S. vs. John Hinckley and Rennie et al vs. New Jersey. In 1989, he was a member of the State Department delegation to inspect the political use of psychiatry in the Soviet Union.
Dr. Carpenter chairs the Scientific Program Committee
Joined the Scientific Council Founding Member in 1986
NARSAD Grants: Distinguished Investigator in 1996, 2001 and 2008
Prizes: Lieber Prize for Outstanding Achievement in Schizophrenia Research in 2000
J. Raymond DePaulo, Jr., M.D.
Henry Phipps Professor and Director
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Dr. DePaulo is a widely recognized clinician, teacher and researcher in the area of mood disorders. The mood disorders program he founded at Johns Hopkins in 1977 includes both clinical services and multi-faceted research projects involving genetic, brain imaging, treatment and educational investigations of bipolar and unipolar disorders. His laboratory group is best known for defining a number of familial sub-types of bipolar disorder.
Dr. DePaulo is devoted to advancing public understanding of mental illness. Since 1986, he has hosted a popular annual Johns Hopkins Mood Disorders Symposium for the general and professional public featuring the perspectives of clinicians, research leaders, patients and their family members. His most recent book, “Understanding Depression” was published in 2002.
Distinctions: Chair of Dept
Joined the Scientific Council in 1996
NARSAD Grants: Distinguished Investigator in 1998 and 2003
Prizes: Selo Prize for Outstanding Achievement in Depression Research in 1996 (re-named the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2012)
Daniel S. Pine, M.D.
Chief, Emotion, and Development Branch
Chief, Child and Adolescent Research in the Mood and Anxiety Disorders Program
National Institute of Mental Health (NIMH)
Throughout his career, Dr. Pine has engaged in research focusing on the epidemiology, biology and treatment of brain and behavior disorders in children and adolescents. His areas of expertise include biological and pharmacological aspects of mood, anxiety and behavioral disorders in children; the biological commonalities and differences among psychiatric disorders of children, adolescents and adults; and the interfaces between psychiatric and medical disorders. Currently, he and his group are examining the degree to which mood and anxiety disorders in children and adolescents are associated with underlying abnormalities in the amygdala, prefrontal cortex and other brain regions.
Prior to joining the NIMH, Dr. Pine spent 10 years at the Department of Child and Adolescent Psychiatry in the New York State Psychiatric Institute and the College of Physicians and Surgeons of Columbia University.
Joined the Scientific Council in 2005 and he is a member of the Ruane Prize Selection Committee.
NARSAD Grants: Independent Investigator in 2000
Prizes: 2011 Ruane Prize for Outstanding Achievement in Child and Adolescent Psychiatric Research
Robert M. Post, M.D.
Head, Bipolar Collaborative Network
Professor of Psychiatry
George Washington School of Medicine
Throughout his career, including 35 years at the National Institute of Mental Health (NIMH), and 20 of those as chief of the Biological Psychiatry Branch, Dr. Post has focused on bettering the understanding and treatment of refractory unipolar and bipolar illness. He founded the international Stanley Foundation Bipolar Network (now the Bipolar Collaborative Network). Currently, he is in private practice and attempting to address childhood-onset bipolar illness.
Dr. Post helped pioneer the use of the anticonvulsant carbamazepine as treatment for lithium-resistant patients with bipolar disorder. Prior to leaving the NIMH, he and his group were exploring nonconvulsive brain stimulation with repetitive transcranial magnetic stimulation (rTMS) for treatment of unipolar and bipolar depression. Animal studies have enabled him to re-conceptualize affective illness recurrence and evolution at the level of cyclic alterations in gene expression. These views emphasize the importance of early, long-term treatment of mood disorders to prevent progressively increasing vulnerability to episode recurrence, cycle acceleration, and treatment resistance.
Joined the Scientific Council in 1992 and he Chairs the Colvin Prize Selection Committee.
Prizes: Selo Prize for Outstanding Achievement in Depression Research in 1993 (re-named the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2012)
Joseph B. Rayman, Ph.D.
Associate Research Scientist
Dept. of Neuroscience, Laboratory of Nobel Prizewinner Eric Kandel
Joseph Rayman is an Associate Research Scientist in the Department of Neuroscience at Columbia University Medical Center, in the laboratory of Eric Kandel. Dr. Rayman’s research focus is on the development of translationally relevant mouse models of post-traumatic stress disorder (PTSD) and drug addiction. Dr. Rayman received a Ph.D. in Biochemistry from Harvard University.